techco:company:beigene
BeOne Medicines
百济神州 · BeOne Medicines Ltd.
BeOne Medicines is a Cambridge-headquartered technology company that develops oncology drugs.
BeOne Medicines is an American technology company founded in 2010 and associated with Co-founder Xiaodong Wang.1 It develops oncology drugs.1 Formerly BeiGene, the company also lists in Hong Kong as 6160 and in Shanghai as 688235.
History
Xiaodong Wang and John Oyler founded BeiGene in 2010. The oncology company later rebranded as BeOne Medicines and keeps a major U.S. presence in Cambridge, Massachusetts.1
Inclusion
This firm is included because at least one named founder is ethnic Chinese. It is not a Chinese company. Keep the headquarters country in the first sentence.
Founders
- Xiaodong Wang — Co-founder
Products
- Brukinsa. BTK-inhibitor cancer medicine developed by the company.
See also
Sources
- BeOne Medicines . Wikipedia. Accessed 2026-09-12.